Grown Rogue International (GRUSF) Operating Leases (2017 - 2026)
Grown Rogue International's (GRUSF) quarterly Operating Leases came in at $14.6 million in Q1 2026, up 229.19% year-on-year from $4.4 million in Q1 2025, and up 12.09% quarter-over-quarter from $13.0 million in Q4 2025.
Grown Rogue International (GRUSF) Operating Leases (2017 - 2026) Analysis & Trends
Grown Rogue International's Operating Leases history runs 10 years deep, the most recent figure standing at $14.6 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 229.19% year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $14.6 million, a 229.19% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, up 94.2% from the prior year.
- Operating Leases advanced to $14.6 million in Q1 2026 per GRUSF's latest filing, from $13.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $4368.9 billion in Q3 2025 and bottomed at $1.2 million in Q2 2023.
- The 5-year median for Operating Leases is $2.4 million (2023), against an average of $312.1 billion.
- Across the five-year window, Operating Leases decreased 26.49% in 2022 and soared 164744047.31% in 2025, its largest moves.
- Year by year, Operating Leases stood at $1.3 million in 2022, then climbed by 13.55% to $1.4 million in 2023, then jumped by 362.51% to $6.7 million in 2024, then soared by 94.2% to $13.0 million in 2025, then increased by 12.09% to $14.6 million in 2026.
- Per Business Quant, the three latest GRUSF Operating Leases figures stand at $14.6 million (Q1 2026), $13.0 million (Q4 2025), and $4368.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.58 Mn |
| Dec 31, 2025 | 13.01 Mn |
| Sep 30, 2025 | 4,368.87 Bn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.43 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Oct 31, 2023 | 2.09 Mn |
| Apr 30, 2023 | 1.18 Mn |
| Jan 31, 2023 | 1.25 Mn |
| Oct 31, 2022 | 1.28 Mn |
| Oct 31, 2021 | 1.74 Mn |
| Apr 30, 2021 | 731,127.00 |
| Jan 31, 2021 | 740,731.00 |
| Oct 31, 2020 | 16,630.00 |
| Jan 31, 2020 | 50,568.00 |
| Oct 31, 2019 | 12,329.00 |